 Economic Times |
Neuland Lab tanks 5% as USFDA issues observations to Hyderabad facility
Economic Times NEW DELHI: Shares of Neuland Laboratories tanked over 5 per cent in Monday’s trade after the drugmaker that the USFDA has issued two observations, under form 483, to its manufacturing facility (unit 1) at Bonthapally, Hyderabad after inspecting it … Neuland Labs gets 2 USFDA observations for Hyderabad facility |
February 4, 2025
